The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Value Expansion Is Expected For The Gastroesophageal Reflux Disease (GERD) Market Over The Forecast Period?
The market for gastroesophageal reflux disease (gerd) has experienced consistent expansion in its size over recent years. Projections indicate it will increase from $5.33 billion in 2025 to $5.46 billion by 2026, achieving a compound annual growth rate (CAGR) of 2.3%. The expansion observed in the historical period is primarily due to several factors, including the extensive use of antacids and h2 blockers, an increase in obesity prevalence, significant consumption of processed foods, higher rates of clinical diagnosis, and the accessibility of generic PPIs.
The gastroesophageal reflux disease (GERD) market is expected to experience steady growth in the next few years, projected to reach $6.2 billion by 2030 at a compound annual growth rate (CAGR) of 3.3%. This expansion during the forecast period is attributable to the rise in minimally invasive reflux procedures, increasing demand for long-term symptom management, ongoing innovation in endoscopic devices, a growing geriatric population, and heightened patient awareness. Significant trends anticipated in the same period include the increasing long-term use of proton pump inhibitors, greater adoption of minimally invasive GERD procedures, growing awareness regarding lifestyle-based disease management, the expansion of endoscopic treatment options, and higher diagnosis rates resulting from improved screening.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
Which Growth Factors Are Strengthening The Gastroesophageal Reflux Disease (GERD) Market Landscape?
The increasing occurrence of esophageal conditions is projected to stimulate the growth of the gastroesophageal reflux disease (GERD) market in the future. Esophageal diseases refer to medical ailments that affect the esophagus, a muscular tube connecting the mouth to the stomach. The management of esophageal diseases aims to alleviate symptoms, enhance quality of life, and prevent complications, ultimately promoting improved overall health and well-being for gastroesophageal reflux disease-affected individuals. For instance, in January 2023, according to the American Cancer Society, a US-based Professional organization, approximately 21,560 new esophageal cancer cases are diagnosed annually in the United States, with 16,120 deaths resulting from esophageal cancer. Therefore, the expanding prevalence of esophageal diseases is propelling the growth of the gastroesophageal reflux disease (GERD) market.
Which Segment-Based Categories Are Covered In The Gastroesophageal Reflux Disease (GERD) Market?
The gastroesophageal reflux disease (gerd) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
Which Trends Are Supporting The Evolution Of The Gastroesophageal Reflux Disease (GERD) Market?
Key companies operating within the gastroesophageal reflux disease (GERD) market are concentrating on introducing innovative gastroesophageal reflux disease treatment devices to sustain their market position. For example, in April 2023, Laborie Medical Technologies, a US-based medical technology company, launched its new alpHaONE wireless pH-capsule reflux testing diagnostic system, designed specifically for diagnosing gastroesophageal reflux disease (GERD). The system is capable of providing up to 96 hours of monitoring data and boasts a compact design featuring enlarged buttons and a fail-safe capsule delivery system. Furthermore, it incorporates a software application complete with a virtual instruction program and user-customizable symptom buttons to enhance the user experience.
Who Are The Businesses Driving Activity In The Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.
Access The Complete Gastroesophageal Reflux Disease (GERD) Market Report:
Which Region Is The Primary Market For The Gastroesophageal Reflux Disease (GERD) Market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease (gerd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Gastroesophageal Reflux Disease (GERD) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2026, By The Business Research Company
Gastric Cancer Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Esophageal Cancer Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report
Gastroparesis Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
